Australia's most trusted
source of pharma news
Thursday, 25 June 2026
Posted 6 February 2025 AM
AstraZeneca has called on the Federal Government to improve access to medicines through a bridging fund and increased diagnostic tests for diseases that have a high impact on society but go undiagnosed in the early stages.
The pharma giant nominated three areas of focus and six specific recommendations in its 2025-26 pre-budget submission to improve Australian's access to healthcare.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.